Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 2000, p. 2557-2560, Vol. 44, No. 9
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
In Vitro Activity of Trovafloxacin Compared to
Those of Five Antimicrobials against Mycoplasmas Including
Mycoplasma hominis and Ureaplasma urealyticum
Fluoroquinolone-Resistant Isolates That Have Been Genetically
Characterized
C. M.
Bebear,1,*
H.
Renaudin,1
A.
Charron,1
D.
Gruson,1
M.
Lefrancois,2 and
C.
Bebear1
Laboratoire de Bactériologie,
Université Victor Segalen Bordeaux 2, 33076 Bordeaux
Cedex,1 and Laboratoire Pfizer,
91400, Orsay,2 France
Received 28 December 1999/Returned for modification 28 April
2000/Accepted 12 June 2000
The in vitro activity of trovafloxacin against 125 strains of
Mycoplasma species and Ureaplasma urealyticum,
including fluoroquinolone-susceptible and fluoroquinolone-resistant
species, was compared to those of other fluoroquinolones, doxycycline,
and erythromycin. The MIC at which 90% of isolates are inhibited for
all fluoroquinolone-susceptible strains was 0.25 µg/ml. Whatever the
associated mutations, trovafloxacin exhibited greater activity than the
other fluoroquinolones tested against fluoroquinolone-resistant
Mycoplasma hominis and U. urealyticum isolates.
*
Corresponding author. Mailing address: Laboratoire de
Bactériologie, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux cedex, France. Phone: (33)
5.57.57.16.25. Fax: (33) 5.56.93.29.40. E-mail:
cecile.bebear{at}u-bordeaux2.fr.
Antimicrobial Agents and Chemotherapy, September 2000, p. 2557-2560, Vol. 44, No. 9
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Beeton, M. L., Chalker, V. J., Kotecha, S., Spiller, O. B.
(2009). Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. J Antimicrob Chemother
64: 529-538
[Abstract]
[Full Text]
-
Waites, K. B., Crabb, D. M., Duffy, L. B.
(2009). Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101. Antimicrob. Agents Chemother.
53: 2139-2141
[Abstract]
[Full Text]
-
Beeton, M. L., Chalker, V. J., Maxwell, N. C., Kotecha, S., Spiller, O. B.
(2009). Concurrent Titration and Determination of Antibiotic Resistance in Ureaplasma Species with Identification of Novel Point Mutations in Genes Associated with Resistance. Antimicrob. Agents Chemother.
53: 2020-2027
[Abstract]
[Full Text]
-
Geissdorfer, W., Sandner, G., John, S., Gessner, A., Schoerner, C., Schroppel, K.
(2008). Ureaplasma urealyticum Meningitis in an Adult Patient. J. Clin. Microbiol.
46: 1141-1143
[Abstract]
[Full Text]
-
Duffy, L., Glass, J., Hall, G., Avery, R., Rackley, R., Peterson, S., Waites, K.
(2006). Fluoroquinolone Resistance in Ureaplasma parvum in the United States. J. Clin. Microbiol.
44: 1590-1591
[Abstract]
[Full Text]
-
Bebear, C. M., Renaudin, H., Charron, A., Clerc, M., Pereyre, S., Bebear, C.
(2003). DNA Gyrase and Topoisomerase IV Mutations in Clinical Isolates of Ureaplasma spp. and Mycoplasma hominis Resistant to Fluoroquinolones. Antimicrob. Agents Chemother.
47: 3323-3325
[Abstract]
[Full Text]
-
Neumayr, L., Lennette, E., Kelly, D., Earles, A., Embury, S., Groncy, P., Grossi, M., Grover, R., McMahon, L., Swerdlow, P., Waldron, P., Vichinsky, E.
(2003). Mycoplasma Disease and Acute Chest Syndrome in Sickle Cell Disease. Pediatrics
112: 87-95
[Abstract]
[Full Text]
-
Waites, K. B., Crabb, D. M., Bing, X., Duffy, L. B.
(2003). In Vitro Susceptibilities to and Bactericidal Activities of Garenoxacin (BMS-284756) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas. Antimicrob. Agents Chemother.
47: 161-165
[Abstract]
[Full Text]
-
Reinhardt, A. K., Kempf, I., Kobisch, M., Gautier-Bouchardon, A. V.
(2002). Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level. J Antimicrob Chemother
50: 589-592
[Abstract]
[Full Text]
-
Reinhardt, A. K., Bebear, C. M., Kobisch, M., Kempf, I., Gautier-Bouchardon, A. V.
(2002). Characterization of Mutations in DNA Gyrase and Topoisomerase IV Involved in Quinolone Resistance of Mycoplasma gallisepticum Mutants Obtained In Vitro. Antimicrob. Agents Chemother.
46: 590-593
[Abstract]
[Full Text]
-
Deguchi, T., Maeda, S.-I., Tamaki, M., Yoshida, T., Ishiko, H., Ito, M., Yokoi, S., Takahashi, Y., Ishihara, S.
(2001). Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment. J Antimicrob Chemother
48: 742-744
[Full Text]
-
Bébéar, C. M., Grau, O., Charron, A., Renaudin, H., Gruson, D., Bébéar, C.
(2000). Cloning and Nucleotide Sequence of the DNA Gyrase (gyrA) Gene from Mycoplasma hominis and Characterization of Quinolone-Resistant Mutants Selected In Vitro with Trovafloxacin. Antimicrob. Agents Chemother.
44: 2719-2727
[Abstract]
[Full Text]